TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
MLYS

Mineralys Therapeutics, Inc.

Healthcare · Biotechnology

26.90$ -8.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MLYS
Line item 2020 2021 2022 2023 2024 2025
0.00 0.00 0.00 0.00 0.00 0.00
– – – – 0.00 0.00
– – – – 0.00 0.00
0.52 3.27 5.08 1.94 3.47 1.95
0.11 0.48 1.01 0.40 0.49 0.57
0.64 3.76 6.09 2.34 3.96 2.52
-0.64 -3.76 -6.09 -2.34 -3.96 -2.52
0.02 0.01 0.32 – – –
-0.74 -3.89 -5.77 -1.99 -3.66 -2.29
0.02 0.01 -0.37 0.00 -3.66 –
-0.74 -3.89 -5.77 -1.99 -3.66 -2.29
-0.72 -3.89 -6.09 -1.99 -3.66 -2.28

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?